Utama › Karsinoma Urotelial (Sel Transisi) › Wilayah Columbia › Washington
Kajian klinikal Karsinoma Urotelial (Sel Transisi) di Washington, DC
9 kajian untuk Karsinoma Urotelial (Sel Transisi) sedang mencari peserta di lokasi dalam dan sekitar Washington (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Mengambil pesertaFasa 2
- MedStar Georgetown University Hospital, Washington D.C.
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Mengambil pesertaFasa 1
- Johns Hopkins Sibley Memorial Hospital, Washington D.C.
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Mengambil pesertaFasa 1/2
- Sibley Memorial Hospital Pharmacy Department, Washington D.C.
- Sibley Memorial Hospital, Washington D.C.
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Mengambil pesertaFasa 3
- MedStar Washington Hospital Center, Washington D.C.
A Study of Ivonescimab in Combination With Enfortumab Vedotin vs Pembrolizumab in Combination With Enfortumab Vedotin in Metastatic Urothelial Carcinoma
Mengambil pesertaFasa 2/3
- Research Site, Washington D.C.
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
Mengambil pesertaFasa 3
- Medstar Washington Hospital Center, Washington D.C.
Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile C...
Mengambil pesertaFasa 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Mengambil pesertaFasa 2
- Medstar Washington Hospital Center, Washington D.C.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Silver Spring · 7 mi jauh
- Massive Bio SYNERGY-AI site, Bethesda · 7 mi jauh
Kajian Karsinoma Urotelial (Sel Transisi) di bandar lain
- Nashville, TN23 kajian
- New York City, NY22 kajian
- Houston, TX19 kajian
- Dallas, TX18 kajian
- Edison, NJ18 kajian
- Los Angeles, CA17 kajian
- Queens, NY15 kajian
- Chicago, IL14 kajian
- Arlington, VA12 kajian
- San Antonio, TX11 kajian
- Boston, MA11 kajian
- Austin, TX10 kajian
Kajian lain di Washington
- Kanser (semua jenis)58 kajian
- Kanser Paru-paru Bukan Sel Kecil55 kajian
- Kanser Payudara46 kajian
- Kanser Metastatik43 kajian
- Kanser Paru-paru41 kajian
- Kanser Prostat38 kajian
- Obesiti33 kajian
- Kanser Kolorektal29 kajian
- Penyakit Kardiovaskular28 kajian
- Kanser Pundi Kencing26 kajian
- Leukemia Mieloid Akut24 kajian
- Limfoma23 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 7 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.